N-(Phosphonacetyl)-l-aspartate (PALA) in advanced malignant melanoma: A phase II trial of the EORTC malignant melanoma cooperative group

This publication has 13 references indexed in Scilit:

• N-(Phosphonacetyl)-l-aspartate (PALA) in advanced soft tissue sarcoma: a phase II trial of the EORTC soft tissue sarcoma group
  European Journal of Cancer and Clinical Oncology, 1982
• N-(Phosphonacetyl)-l-aspartate (PALA) in advanced breast cancer: a phase II trial of the EORTC breast cancer cooperative group
  European Journal of Cancer and Clinical Oncology, 1982
• PHARMACOLOGICAL DISPOSITION OF N-(PHOSPHONACETYL)-L-ASPARTATE IN HUMANS
  1980
• PHASE-I CLINICAL-STUDY OF N-(PHOSPHONACETYL)-L-ASPARTIC ACID (PALA)
  1980
• PHASE-I TRIAL OF N-(PHOSPHONACETYL)-L-ASPARTATE
  1979
• PHASE-I STUDY OF N-(PHOSPHONACETYL)-L-ASPARTIC ACID (PALA)
  1979
• MECHANISMS OF SENSITIVITY OR RESISTANCE OF MURINE TUMORS TO N-(PHOSPHONACETYL)-L-ASPARTATE (PALA)
  1979
• EFFECTS OF N-(PHOSPHONACETYL)-L-ASPARTATE ON MURINE TUMORS AND NORMAL TISSUES INVIVO AND INVITRO AND RELATIONSHIP OF SENSITIVITY TO RATE OF PROLIFERATION AND LEVEL OF ASPARTATE-TRANSCARBAMYLASE
  1978
• Reversal of toxicity and antitumor activity of N-(phosphonacetyl)-L-aspartate by uridine or carbamyl-DL-aspartate in vivo
  Biochemical Pharmacology, 1977
• Stable mutants of mammalian cells that overproduce the first three enzymes of pyrimidine nucleotide biosynthesis
  Cell, 1976